{"resourceType": "Group", "meta": {"versionId": "3", "lastUpdated": "2023-12-04T20:29:22.185Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"]}, "title": "Remdesivir IV 200 mg once then 100 mg once daily for 9 days", "status": "active", "url": "https://fevir.net/resources/Group/179783", "id": "179783", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "179783", "assigner": {"display": "Computable Publishing LLC"}}], "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "cite-as", "citation": "Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783."}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Brian S. Alper"}}], "description": "Remdesivir IV 200 mg once then 100 mg once daily for 9 days", "membership": "conceptual", "characteristic": [{"description": "Remdesivir IV 200 mg once then 100 mg once daily for 9 days", "code": {"text": "Defined by Reference"}, "valueReference": {"reference": "ActivityDefinition/213", "type": "ActivityDefinition", "display": "IV remdesivir 200 mg then 100 mg/day for 9 days"}, "exclude": false}], "name": "Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days"}